Last 12 months
Inside the activity.
8 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 2 | 0 |
| May 2026 | 6 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 07, 2024 Filed Aug 7, 2024 22:18 UTC |
Westrick Thomas J.CEO, Patient Care Solutions
|
SaleCommon Stock, par value $0.01 per share | 2,750 | $80.78 | $222,145.00 |
DisclosureSEC source: 0001628280-24-035773 · wk-form4_1723069129.xml · nonDerivative · entry 1 Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,509 F1 · price: The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $80.78 to $80.84, inclusive. The Reporting Person undertakes to provide to GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). Read SEC document |
| August 03, 2024 Filed Aug 6, 2024 20:05 UTC |
Rott RolandCEO, Imaging
|
Tax withholdingCommon Stock, par value $0.01 per share | 1,630 | $83.44 | $136,007.20 |
DisclosureSEC source: 0001628280-24-035175 · wk-form4_1722974736.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,199 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| August 03, 2024 Filed Aug 6, 2024 20:05 UTC |
O'Neill Kevin MichaelCEO, PDx
|
Tax withholdingCommon Stock, par value $0.01 per share | 1,533 | $83.44 | $127,913.52 |
DisclosureSEC source: 0001628280-24-035172 · wk-form4_1722974712.xml · nonDerivative · entry 1 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,477 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 12:00 UTC |
SACCARO JAMESChief Financial Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 8,998 | $78.00 | $701,844.00 |
DisclosureSEC source: 0001628280-24-026476 · wk-form4_1717502409.xml · nonDerivative · entry 1 SACCARO JAMES · CIK 0001593636 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,940 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| May 28, 2024 Filed May 29, 2024 20:05 UTC |
Kass-Hout TahaChief Technology Officer
|
SaleCommon Stock, par value $0.01 per share | 3,300 | $78.70 | $259,710.00 |
DisclosureSEC source: 0001628280-24-025602 · wk-form4_1717013112.xml · nonDerivative · entry 1 Kass-Hout Taha · CIK 0001960652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,300 F1 · price: The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $78.70 to $78.72, inclusive. The Reporting Person undertakes to provide to GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:32 UTC |
LAVIZZO-MOUREY RISA JDirector
|
GrantCommon Stock, par value $0.01 per share | 2,440 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-024965 · wk-form4_1716496324.xml · nonDerivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,065 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 21, 2025. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:33 UTC |
Madden Anne TDirector
|
GrantCommon Stock, par value $0.01 per share | 1,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-024968 · wk-form4_1716496379.xml · nonDerivative · entry 2 Madden Anne T · CIK 0001684059 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,763 F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F3 · shares: Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the director's applicable deferral election. Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:33 UTC |
Madden Anne TDirector
|
GrantCommon Stock, par value $0.01 per share | 2,440 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-024968 · wk-form4_1716496379.xml · nonDerivative · entry 1 Madden Anne T · CIK 0001684059 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,238 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 21, 2025. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:31 UTC |
Hochman Rodney FDirector
|
GrantCommon Stock, par value $0.01 per share | 1,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-024963 · wk-form4_1716496251.xml · nonDerivative · entry 2 Hochman Rodney F · CIK 0001468966 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,763 F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F3 · shares: Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the director's applicable deferral election. Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:31 UTC |
Hochman Rodney FDirector
|
GrantCommon Stock, par value $0.01 per share | 2,440 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-024963 · wk-form4_1716496251.xml · nonDerivative · entry 1 Hochman Rodney F · CIK 0001468966 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,238 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 21, 2025. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:34 UTC |
Stromberg William JDirector
|
GrantCommon Stock, par value $0.01 per share | 1,769 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-024973 · wk-form4_1716496466.xml · nonDerivative · entry 2 Stromberg William J · CIK 0001352578 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,201 F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F3 · shares: Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the director's applicable deferral election. Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:34 UTC |
Stromberg William JDirector
|
GrantCommon Stock, par value $0.01 per share | 2,440 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-024973 · wk-form4_1716496466.xml · nonDerivative · entry 1 Stromberg William J · CIK 0001352578 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,432 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 21, 2025. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:30 UTC |
CULP H LAWRENCE JRDirector
|
GrantCommon Stock, par value $0.01 per share | 2,440 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-024961 · wk-form4_1716496211.xml · nonDerivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 624,074 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 21, 2025. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:32 UTC |
LESJAK CATHERINE ADirector
|
GrantCommon Stock, par value $0.01 per share | 2,440 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-024967 · wk-form4_1716496353.xml · nonDerivative · entry 1 LESJAK CATHERINE A · CIK 0001256992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,024 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 21, 2025. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 21, 2024 Filed May 23, 2024 16:31 UTC |
HOWELL LLOYD JRDirector
|
GrantCommon Stock, par value $0.01 per share | 2,440 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-024964 · wk-form4_1716496284.xml · nonDerivative · entry 1 HOWELL LLOYD JR · CIK 0001505488 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,024 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 21, 2025. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:34 UTC |
Mihaljevic TomislavDirector
|
GrantCommon Stock, par value $0.01 per share | 2,440 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-024971 · wk-form4_1716496434.xml · nonDerivative · entry 1 Mihaljevic Tomislav · CIK 0001917584 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,024 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 21, 2025. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:35 UTC |
Yang Watkin Phoebe L.Director
|
GrantCommon Stock, par value $0.01 per share | 2,440 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-024975 · wk-form4_1716496489.xml · nonDerivative · entry 1 Yang Watkin Phoebe L. · CIK 0001940538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,024 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 21, 2025. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 15, 2024 Filed May 15, 2024 23:15 UTC |
Makela JanCEO, Imaging
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 33,095 | $0.00 Strike: $76.37 | $0.00 |
DisclosureSEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · derivative · entry 10 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,096 Underlying: Common Stock, par value $0.01 per share · 33,095 shares Expires 2031-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% became exercisable on July 1, 2023 and 50% will become exercisable on July 1, 2024. Read SEC document |
| May 15, 2024 Filed May 15, 2024 23:15 UTC |
Makela JanCEO, Imaging
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 25,472 | $0.00 Strike: $75.30 | $0.00 |
DisclosureSEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · derivative · entry 9 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 25,472 shares Expires 2033-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 100% became exercisable on March 1, 2024. Read SEC document |
| May 15, 2024 Filed May 15, 2024 23:15 UTC |
Makela JanCEO, Imaging
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,388 | $0.00 Strike: $63.51 | $0.00 |
DisclosureSEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · derivative · entry 8 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 8,388 shares Expires 2030-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% became exercisable on March 2, 2023. Read SEC document |
| May 15, 2024 Filed May 15, 2024 23:15 UTC |
Makela JanCEO, Imaging
|
SaleCommon Stock, par value $0.01 per share | 66,955 | $81.54 | $5,459,510.70 |
DisclosureSEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · nonDerivative · entry 6 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,348 F2 · price: The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $81.50 to $81.68, inclusive. The Reporting Person undertakes to provide GE HealthCare, any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2). Read SEC document |
| May 15, 2024 Filed May 15, 2024 23:15 UTC |
Makela JanCEO, Imaging
|
Exercise / conversionCommon Stock, par value $0.01 per share | 33,095 | $76.37 | $2,527,465.15 |
DisclosureSEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · nonDerivative · entry 5 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2024 Filed May 15, 2024 23:15 UTC |
Makela JanCEO, Imaging
|
Exercise / conversionCommon Stock, par value $0.01 per share | 25,472 | $75.30 | $1,918,041.60 |
DisclosureSEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · nonDerivative · entry 4 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2024 Filed May 15, 2024 23:15 UTC |
Makela JanCEO, Imaging
|
Exercise / conversionCommon Stock, par value $0.01 per share | 8,388 | $63.51 | $532,721.88 |
DisclosureSEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · nonDerivative · entry 3 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,736 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2024 Filed May 15, 2024 23:15 UTC |
Makela JanCEO, Imaging
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 20,227 | $0.00 Strike: $63.51 | $0.00 |
DisclosureSEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · derivative · entry 7 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,388 Underlying: Common Stock, par value $0.01 per share · 20,227 shares Expires 2030-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% became exercisable on March 2, 2023. Read SEC document |
| May 13, 2024 Filed May 15, 2024 23:15 UTC |
Makela JanCEO, Imaging
|
SaleCommon Stock, par value $0.01 per share | 20,227 | $81.57 | $1,649,916.39 |
DisclosureSEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · nonDerivative · entry 2 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,348 F1 · price: The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $81.50 to $81.84, inclusive. The Reporting Person undertakes to provide GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). Read SEC document |
| May 13, 2024 Filed May 15, 2024 23:15 UTC |
Makela JanCEO, Imaging
|
Exercise / conversionCommon Stock, par value $0.01 per share | 20,227 | $63.51 | $1,284,616.77 |
DisclosureSEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · nonDerivative · entry 1 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,575 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2024 Filed May 2, 2024 10:00 UTC |
Jimenez Frank RGC & Corporate Secretary
|
PurchaseCommon Stock, par value $0.01 per share | 1,315 | $76.52 | $100,623.80 |
DisclosureSEC source: 0001628280-24-019724 · wk-form4_1714644029.xml · nonDerivative · entry 1 Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,796 Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 22:41 UTC |
Rott RolandCEO, Ultrasound
|
Tax withholdingCommon Stock, par value $0.01 per share | 837 | $90.91 | $76,091.67 |
DisclosureSEC source: 0001628280-24-014445 · wk-form4_1712097697.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,829 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 15, 2024 Filed Mar 15, 2024 20:03 UTC |
GENERAL ELECTRIC COFormer 10% Owner
|
OtherCommon stock, par value $0.01 per share | 14,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950142-24-000720 · es240458409_4-ge.xml · nonDerivative · entry 1 GENERAL ELECTRIC CO · CIK 0000040545 · Former 10% Owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,631,302 F1 · security: The reporting person exchanged 14,000,000 shares of the common stock of the Issuer to extinguish $1,221,780,000 aggregate principal amount of indebtedness under a short-term credit facility of the reporting person in a debt-for-equity exchange. F1 · kind: The reporting person exchanged 14,000,000 shares of the common stock of the Issuer to extinguish $1,221,780,000 aggregate principal amount of indebtedness under a short-term credit facility of the reporting person in a debt-for-equity exchange. F2 · price: The value of the Issuer's common stock for purposes of the debt-for-equity exchange was $87.27 per share. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 17:55 UTC |
Stacherski Kenneth R.Ch. Supply Chain & Serv. Ofc.
|
GrantEmployee Stock Option (right to buy) · Derivative | 13,420 | $0.00 Strike: $92.72 | $0.00 |
DisclosureSEC source: 0001628280-24-009085 · wk-form4_1709679338.xml · derivative · entry 2 Stacherski Kenneth R. · CIK 0001889865 · Ch. Supply Chain & Serv. Ofc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,420 Underlying: Common Stock, par value $0.01 per share · 13,420 shares Expires 2034-03-01 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 17:55 UTC |
Stacherski Kenneth R.Ch. Supply Chain & Serv. Ofc.
|
GrantCommon Stock, par value $0.01 per share | 4,718 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-009085 · wk-form4_1709679338.xml · nonDerivative · entry 1 Stacherski Kenneth R. · CIK 0001889865 · Ch. Supply Chain & Serv. Ofc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,549 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:51 UTC |
Jimenez Frank RGC & Corporate Secretary
|
GrantEmployee Stock Option (right to buy) · Derivative | 26,840 | $0.00 Strike: $92.72 | $0.00 |
DisclosureSEC source: 0001628280-24-009072 · wk-form4_1709679097.xml · derivative · entry 4 Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,840 Underlying: Common Stock, par value $0.01 per share · 26,840 shares Expires 2034-03-01 F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:51 UTC |
Jimenez Frank RGC & Corporate Secretary
|
GrantCommon Stock, par value $0.01 per share | 9,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-009072 · wk-form4_1709679097.xml · nonDerivative · entry 3 Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,481 F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions. F3 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:51 UTC |
Jimenez Frank RGC & Corporate Secretary
|
Tax withholdingCommon Stock, par value $0.01 per share | 4,841 | $91.28 | $441,886.48 |
DisclosureSEC source: 0001628280-24-009072 · wk-form4_1709679097.xml · nonDerivative · entry 2 Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,044 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:51 UTC |
Jimenez Frank RGC & Corporate Secretary
|
Tax withholdingCommon Stock, par value $0.01 per share | 6,443 | $91.28 | $588,117.04 |
DisclosureSEC source: 0001628280-24-009072 · wk-form4_1709679097.xml · nonDerivative · entry 1 Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,885 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:50 UTC |
CULP H LAWRENCE JRDirector
|
Tax withholdingCommon Stock, par value $0.01 per share | 31,290 | $91.28 | $2,856,151.20 |
DisclosureSEC source: 0001628280-24-009067 · wk-form4_1709679019.xml · nonDerivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 621,634 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of performance stock units previously reported by the reporting person in the Form 4 filed with the Securities and Exchange Commission on December 29, 2023. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:51 UTC |
Arduini Peter JDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 103,527 | $0.00 Strike: $92.72 | $0.00 |
DisclosureSEC source: 0001628280-24-009069 · wk-form4_1709679058.xml · derivative · entry 3 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,527 Underlying: Common Stock, par value $0.01 per share · 103,527 shares Expires 2034-03-01 F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:51 UTC |
Arduini Peter JDirector · President and CEO
|
GrantCommon Stock, par value $0.01 per share | 36,399 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-009069 · wk-form4_1709679058.xml · nonDerivative · entry 2 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,200 F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions. F3 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:51 UTC |
Arduini Peter JDirector · President and CEO
|
Tax withholdingCommon Stock, par value $0.01 per share | 4,444 | $91.28 | $405,648.32 |
DisclosureSEC source: 0001628280-24-009069 · wk-form4_1709679058.xml · nonDerivative · entry 1 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,801 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:55 UTC |
SACCARO JAMESChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 29,141 | $0.00 Strike: $92.72 | $0.00 |
DisclosureSEC source: 0001628280-24-009083 · wk-form4_1709679314.xml · derivative · entry 2 SACCARO JAMES · CIK 0001593636 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,141 Underlying: Common Stock, par value $0.01 per share · 29,141 shares Expires 2034-03-01 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:55 UTC |
SACCARO JAMESChief Financial Officer
|
GrantCommon Stock, par value $0.01 per share | 10,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-009083 · wk-form4_1709679314.xml · nonDerivative · entry 1 SACCARO JAMES · CIK 0001593636 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,938 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:53 UTC |
Larson Betty DChief People Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 3,523 | $91.28 | $321,579.44 |
DisclosureSEC source: 0001628280-24-009076 · wk-form4_1709679168.xml · nonDerivative · entry 2 Larson Betty D · CIK 0001617903 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,936 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:53 UTC |
Larson Betty DChief People Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 7,472 | $91.28 | $682,044.16 |
DisclosureSEC source: 0001628280-24-009076 · wk-form4_1709679168.xml · nonDerivative · entry 1 Larson Betty D · CIK 0001617903 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,459 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:56 UTC |
Westrick Thomas J.CEO, Patient Care Solutions
|
GrantEmployee Stock Option (right to buy) · Derivative | 8,435 | $0.00 Strike: $92.72 | $0.00 |
DisclosureSEC source: 0001628280-24-009086 · wk-form4_1709679363.xml · derivative · entry 6 Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,435 Underlying: Common Stock, par value $0.01 per share · 8,435 shares Expires 2034-03-01 F5 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. F5 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:56 UTC |
Westrick Thomas J.CEO, Patient Care Solutions
|
GrantCommon Stock, par value $0.01 per share | 2,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-009086 · wk-form4_1709679363.xml · nonDerivative · entry 5 Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,259 F3 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions. F4 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:56 UTC |
Westrick Thomas J.CEO, Patient Care Solutions
|
Tax withholdingCommon Stock, par value $0.01 per share | 2,121 | $91.28 | $193,604.88 |
DisclosureSEC source: 0001628280-24-009086 · wk-form4_1709679363.xml · nonDerivative · entry 4 Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,294 F2 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of performance stock units previously reported by the reporting person in the Form 4 filed with the Securities and Exchange Commission on December 29, 2023. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:56 UTC |
Westrick Thomas J.CEO, Patient Care Solutions
|
Tax withholdingCommon Stock, par value $0.01 per share | 1,169 | $91.28 | $106,706.32 |
DisclosureSEC source: 0001628280-24-009086 · wk-form4_1709679363.xml · nonDerivative · entry 3 Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,415 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:56 UTC |
Westrick Thomas J.CEO, Patient Care Solutions
|
Tax withholdingCommon Stock, par value $0.01 per share | 1,285 | $91.28 | $117,294.80 |
DisclosureSEC source: 0001628280-24-009086 · wk-form4_1709679363.xml · nonDerivative · entry 2 Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,584 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:56 UTC |
Westrick Thomas J.CEO, Patient Care Solutions
|
Tax withholdingCommon Stock, par value $0.01 per share | 1,195 | $91.28 | $109,079.60 |
DisclosureSEC source: 0001628280-24-009086 · wk-form4_1709679363.xml · nonDerivative · entry 1 Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,869 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.